Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;74(6):1424-1431.
doi: 10.1016/j.identj.2024.04.014. Epub 2024 May 1.

Exploring the Prevalence of Oral Features for Early Detection of PTEN Hamartoma Tumour Syndrome

Affiliations

Exploring the Prevalence of Oral Features for Early Detection of PTEN Hamartoma Tumour Syndrome

Ane J Schei-Andersen et al. Int Dent J. 2024 Dec.

Abstract

Aims: Patients with PTEN hamartoma tumour syndrome (PHTS) have an increased risk of developing cancer due to a pathogenic germline variant in the PTEN tumour suppressor gene. Early recognition of PHTS facilitates initiation of cancer surveillance which is highly effective in preventing the development of advanced malignancies. PHTS is rare and due to its varied phenotype, even within families, oral abnormalities may be a valuable tool in the identification of these patients at an early stage before cancer development.

Materials and methods: Between 1997 and 2020, phenotypic characteristics were evaluated in 81 paediatric (median age: 9 years) and 86 adult (median age: 40 years) PHTS patients by one of 2 medical experts during yearly surveillance visits at a Dutch PHTS expertise centre. Oral features evaluated included gingival hypertrophy, oral papillomas, and high palate (in adults).

Results: Within adults, gingival hypertrophy was present in 94%, oral papillomas in 88%, and a high palate in 89%. All adult patients had at least one of these oral features, and 99% showed at least 2 oral features. Oral features were less common in paediatric patients, especially under 11 years of age. Gingival hypertrophy was observed in 44% and oral papillomas in 54% of paediatric patients.

Conclusions: The presence of 2 or 3 oral features may indicate PHTS in adults or adolescents, especially if macrocephaly is present. Dental professionals are well-positioned to recognise these oral manifestations could be related to PHTS. They can initiate an overall clinical assessment of the patient by alerting the patient's medical practitioner of the findings and the possible need for genetic testing. This could significantly improve outcomes, including life expectancy, for patients and possibly for their relatives.

Clinical relevance: Dental professionals are ideally placed to recognise oral features and initiate early assessment of PHTS which could significantly improve patient outcomes.

Keywords: Cowden syndrome; PHTS; PTEN; Phenotype; Prevention; Recognition.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest None disclosed.

Figures

Figure 1
Figure 1
Age distribution of oral features in PHTS patients. (A) Gingival hypertrophy, (B) high palate (adults only), (C) oral papillomas, and (D) ≥2 out of 3 oral features.
Figure 2
Figure 2
Gingival hypertrophy. (A-D) Hypertrophy of gingival tissue in PHTS patients. In (B), papilloma of the lip is also present and in (D) papillomatosis of the gingival tissue is present.
Figure 3
Figure 3
Papillary tongue. (A-C) Papillary tongue: papillomas of the tongue affecting the entire dorsal surface to the line of circumvallate papillae.
Figure 4
Figure 4
Papillary buccal mucosa. Papillomas of the buccal mucosa.
Figure 5
Figure 5
High palate, here defined as a palatal height twice the height of the first permanent molar.

Similar articles

References

    1. Mester J, Eng C. Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome. J Surg Oncol. 2015;111(1):125–130. - PubMed
    1. Ngeow J, Eng C. PTEN hamartoma tumor syndrome: Clinical risk assessment and management protocol. Methods. 2015;77:11–19. - PubMed
    1. Pilarski R. PTEN hamartoma tumor syndrome: a clinical overview. Cancers. 2019;11(6):844. - PMC - PubMed
    1. Yehia L, Keel E, Eng C. The clinical spectrum of PTEN mutations. Annu Rev Med. 2020;71(1):103–116. - PubMed
    1. Hendricks LAJ, Hoogerbrugge N, Schuurs-Hoeijmakers JHM, Vos JR. A review on age-related cancer risks in PTEN hamartoma tumor syndrome. Clin Genet. 2021;99(2):219–225. - PMC - PubMed